These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24980293)

  • 41. [Expression of HIF-1alpha and VEGF in human laryngeal carcinoma and its relationship with angiogenes].
    Qiu Y; Zhou H
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 28(6):389-93. PubMed ID: 24961126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung.
    Morise M; Hishida T; Takahashi A; Yoshida J; Ohe Y; Nagai K; Ishii G
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2121-30. PubMed ID: 25963795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinicopathological implications of the expression of hypoxia-related proteins in gastric cancer.
    Jung JH; Im S; Jung ES; Kang CS
    Int J Med Sci; 2013; 10(9):1217-23. PubMed ID: 23935399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression and significance of hypoxia-inducible factor-1α and survivin in laryngeal carcinoma tissue and cells.
    Li DW; Zhou L; Jin B; Xie J; Dong P
    Otolaryngol Head Neck Surg; 2013 Jan; 148(1):75-81. PubMed ID: 23087365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
    Zhou JT; Cai ZM; Li NC; Na YQ
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinicopathological significance and linkage of the distribution of HIF-1alpha and GLUT-1 in human primary colorectal cancer.
    Wincewicz A; Sulkowska M; Koda M; Sulkowski S
    Pathol Oncol Res; 2007; 13(1):15-20. PubMed ID: 17387384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of Hypoxia-inducible factor-1 α , glucose transporter-1, (GLUT-1) and carbon anhydrase IX in endometrial cancer patients.
    Sadlecki P; Bodnar M; Grabiec M; Marszalek A; Walentowicz P; Sokup A; Zegarska J; Walentowicz-Sadlecka M
    Biomed Res Int; 2014; 2014():616850. PubMed ID: 24745019
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A multicenter study of the importance of systemic chemotherapy for patients with small-cell neuroendocrine carcinoma of the uterine cervix.
    Lee SW; Lim KT; Bae DS; Park SY; Kim YT; Kim KR; Nam JH
    Gynecol Obstet Invest; 2015; 79(3):172-8. PubMed ID: 25500455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.
    Seeber LM; Horrée N; van der Groep P; van der Wall E; Verheijen RH; van Diest PJ
    BMC Cancer; 2010 Jun; 10():307. PubMed ID: 20565904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HIF-1α expression correlates with cellular apoptosis, angiogenesis and clinical prognosis in rectal carcinoma.
    Feng L; Tao L; Dawei H; Xuliang L; Xiaodong L
    Pathol Oncol Res; 2014 Jul; 20(3):603-10. PubMed ID: 24374863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical analysis of nasal and laryngeal neuroendocrine carcinoma].
    Gu Q; Li J; Feng Y; Fan J; He G; Zhu H; Zhou S; Wang S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 May; 27(9):451-4. PubMed ID: 23898607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The relation between hypoxia-inducible factor (HIF)-1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer.
    Cabanillas R; Rodrigo JP; Secades P; Astudillo A; Nieto CS; Chiara MD
    J Surg Oncol; 2009 May; 99(6):373-8. PubMed ID: 19226532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The prognostic significance of Omi/HtrA2 expression, and correlation between Omi/HtrA2 and hypoxia-inducible factor-1α in primary hepatocellular carcinoma cells].
    Xu ZQ; Chen XP; Niu J; Liu EY; Li CH; Peng C
    Zhonghua Wai Ke Za Zhi; 2012 Jan; 50(1):49-52. PubMed ID: 22490291
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of INSM1 in Diagnosis and Grading of Laryngeal Neuroendocrine Carcinoma.
    Yuan C; Jiao F; Zhai C; Zhang J; Wang S; Zhu L
    Laryngoscope; 2021 Oct; 131(10):E2662-E2668. PubMed ID: 33847383
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypoxia-inducible factor-1α and excision repair cross-complementing 1 in patients with small cell lung cancer who received front-line platinum-based chemotherapy: a retrospective study.
    Lee GW; Go SI; Cho YJ; Jeong YY; Kim HC; Duk Lee J; Hwang YS; Ko GH; Lee JH; Kim DC; Yang JW; Oh S; Lee JS
    J Thorac Oncol; 2012 Mar; 7(3):528-34. PubMed ID: 22258474
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SMARCA4-deficient Sinonasal Carcinoma: A Series of 10 Cases Expanding the Genetic Spectrum of SWI/SNF-driven Sinonasal Malignancies.
    Agaimy A; Jain D; Uddin N; Rooper LM; Bishop JA
    Am J Surg Pathol; 2020 May; 44(5):703-710. PubMed ID: 31934917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Analysis of clinicopathological features of intestinal neuroendocrine neoplasms].
    Gao W; Liu SM; Lu HZ; Liang J; Yuan YL; Liu XY
    Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):450-6. PubMed ID: 22967448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer.
    Zhang J; Wu Y; Lin YH; Guo S; Ning PF; Zheng ZC; Wang Y; Zhao Y
    World J Gastroenterol; 2018 Jun; 24(22):2381-2391. PubMed ID: 29904245
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Construction of a GLUT-1 and HIF-1α gene knockout cell model in HEp-2 cells using the CRISPR/Cas9 technique.
    Lu ZJ; Yu Q; Zhou SH; Fan J; Shen LF; Bao YY; Wu TT; Zhou ML; Huang YP
    Cancer Manag Res; 2019; 11():2087-2096. PubMed ID: 30881132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.